CBP-307

· Connect Biopharma Australia Pty Ltd

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CBP-307, covering 2016-11-03 to 2024-11-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects [Phase 1]

See pricing